Safety and effectiveness of insulin analogues in Moroccan patients with type 2 diabetes: a sub-analysis of the A1chieve study
References (18)
- et al.
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Diab Res Clin Pract
(2011) - et al.
An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study
Diabetes Res Clin Pract
(2011) - et al.
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
Clin Ther
(2006) - et al.
Towards a better future in Morocco
Diabetes Voice
(2006) - et al.
Prevalence of the main cardiovascular risk factors in Morocco: results of a national survey in 2000
J Hypertens
(2003) - et al.
Diabetes in the Eastern Mediterranean (Middle East) region: the World Health Organization responds to a major public health challenge
Diabet Med
(1995) Nutrition transition in Morocco
Public Health Nutr
(2002)- et al.
Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region
Int J Gen Med
(2012) - et al.
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diabetologia
(2012)
There are more references available in the full text version of this article.
Cited by (2)
Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus
2016, International Journal of Clinical PracticeDrug-related risk of severe hypoglycaemia in observational studies: A systematic review and meta-analysis
2015, BMC Endocrine Disorders
Copyright © 2013 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.